{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:48:50Z","timestamp":1790887730839,"version":"4.1.0"},"reference-count":63,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T00:00:00Z","timestamp":1661299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There are numerous reports of cancers in Gaucher disease (GD) from mostly small single\u2010center studies; however, precise risk estimates and cancer types involved have not been delineated. We conducted a study involving 2123 patients with GD type 1 (GD1) to assess the incidence of hematological malignancies, gammopathies, and solid tumors in an international observational study, the International Cooperative Gaucher Group Gaucher Registry (Clinicaltrials.gov: NCT00358943). Risk for cancer overall and for each type of malignancy was compared to the United States (US) population using the Surveillance, Epidemiology, and End Results database. Natural history of gammopathy was determined through assessing the progression from a diagnosis of monoclonal gammopathy of unknown significance (MGUS) to multiple myeloma (MM). Risk for hematological malignancies was more than four times higher than expected compared to the general population: non\u2010Hodgkin lymphoma was approximately three times higher; MM was approximately nine times higher. Age\u2010specific incidence rates of MGUS were unexpectedly high among younger patients. The 10\u2010year cumulative incidence of MM after diagnosis of MGUS was 7.9%, comparable to the general population. Compared to the general US population, GD1 patients were at higher risk for solid malignancies of liver (2.9 times), kidney (2.8 times), melanoma (2.5 times), and breast (1.4 times). Colorectal, prostate, and lung cancer risks were lower than expected. These findings help advance care of patients with GD1 by supporting recommendations for individualized monitoring for malignancies and antecedents such as MGUS for MM and provoke important questions of the role of glucosylceramide and related sphingolipids in cancer biology.<\/jats:p>","DOI":"10.1002\/ajh.26675","type":"journal-article","created":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T19:34:16Z","timestamp":1659468856000},"page":"1337-1347","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry"],"prefix":"10.1002","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3217-4318","authenticated-orcid":false,"given":"Barry E.","family":"Rosenbloom","sequence":"first","affiliation":[{"name":"Department of Medicine Cedars\u2010Sinai Medical Center  Los Angeles California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8676-6864","authenticated-orcid":false,"given":"Maria Domenica","family":"Cappellini","sequence":"additional","affiliation":[{"name":"Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico Milano  Milan Italy"},{"name":"Department of Internal Medicine University of Milan  Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Weinreb","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine University of Miami Miller School of Medicine  Miami Florida USA"},{"name":"Division of Clinical Genetics, Department of Human Genetics University of Miami Miller School of Medicine  Miami Florida USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Dragosky","sequence":"additional","affiliation":[{"name":"Department of Hematology Henry Moore Institute  Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9151-0337","authenticated-orcid":false,"given":"Shoshana","family":"Revel\u2010Vilk","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology, School of Medicine Hebrew University  Jerusalem Israel"},{"name":"Gaucher Unit, Shaare Zedek Medical Center  Jerusalem Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Batista","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics Sanofi  Cambridge Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davorka","family":"Sekulic","sequence":"additional","affiliation":[{"name":"Global Medical Affairs Hematology, Sanofi, Cambridge  Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-6421","authenticated-orcid":false,"given":"Pramod K.","family":"Mistry","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Yale University School of Medicine  New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,8,24]]},"reference":[{"key":"e_1_2_10_2_1","volume-title":"The Online Metabolic and Molecular Bases of Inherited Disease","author":"Grabowski GA","year":"2014"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-008-0832-y"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2011.03.005"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1702"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevOncog.2013006145"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2014.07.013"},{"key":"e_1_2_10_9_1","unstructured":"National Cancer Institute.Surveillance Epidemiology and End Results (SEER) Program SEER*Stat Database: incidence\u2014SEER 13 Regs Research Data Nov 2020 Sub (1992\u20102018) National Cancer Institute DCCPS Surveillance Research Program Surveillance Systems Branch. Accessed November 2020.www.seer.cancer.gov."},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176350951"},{"key":"e_1_2_10_11_1","unstructured":"American Cancer Society.Cancer facts and figures for African Americans 2019\u20102021. Accessed June 28 2022.https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/cancer-facts-and-figures-for-african-americans\/cancer-facts-and-figures-for-african-americans-2019-2021.pdf."},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21362"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120002495"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2020.12.295"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.08.004"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-12-4672"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2005.03.004"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.11.1189"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12020475"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0214530"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2020.01.009"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508808"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.06.014"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041247"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biochi.2015.11.009"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709974"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-12-194241"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-008-0441-8"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2003.10.007"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2011.09.005"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2009.04.002"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-009-1207-8"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98259"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4227"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.4452"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26276"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2020.100663"},{"key":"e_1_2_10_38_1","unstructured":"National Cancer Institute.Cancer stat facts: myeloma. Surveillance epidemiology and end results program. Accessed September 8 2021.https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html."},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2018.05.007"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1586\/14737140.2015.1023712"},{"key":"e_1_2_10_41_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.580474"},{"key":"e_1_2_10_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-10-3230"},{"key":"e_1_2_10_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-018-0142-y"},{"key":"e_1_2_10_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-019-0954-3"},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.12.001"},{"issue":"1","key":"e_1_2_10_46_1","first-page":"31","article-title":"Body composition and bone metabolism in young Gaucher disease type I patients treated with imiglucerase","volume":"13","author":"Parisi MS","year":"2008","journal-title":"Eur J Med Res."},{"key":"e_1_2_10_47_1","doi-asserted-by":"publisher","DOI":"10.1006\/bcmd.2002.0517"},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1211-5"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2010.09.002"},{"issue":"9","key":"e_1_2_10_50_1","first-page":"3511","article-title":"The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature","volume":"29","author":"K\u00f6stner K","year":"2009","journal-title":"Anticancer Res."},{"key":"e_1_2_10_51_1","first-page":"177","article-title":"The pathology of Gaucher disease","volume":"95","author":"Lee RE","year":"1982","journal-title":"Prog Clin Biol Res."},{"key":"e_1_2_10_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2016.10.002"},{"key":"e_1_2_10_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-0650-1_7"},{"key":"e_1_2_10_54_1","doi-asserted-by":"publisher","DOI":"10.1159\/000356498"},{"key":"e_1_2_10_55_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25734"},{"key":"e_1_2_10_56_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31821e554e"},{"key":"e_1_2_10_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-017-2704-y"},{"key":"e_1_2_10_58_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fb4466"},{"key":"e_1_2_10_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.06.001"},{"key":"e_1_2_10_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2012.08.010"},{"key":"e_1_2_10_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)91485-3"},{"key":"e_1_2_10_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003871"},{"key":"e_1_2_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acr.2018.12.003"},{"key":"e_1_2_10_64_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2019.303594"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26675","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.26675","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.26675","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T19:59:45Z","timestamp":1692475185000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.26675"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,24]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10.1002\/ajh.26675"],"URL":"https:\/\/doi.org\/10.1002\/ajh.26675","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,24]]},"assertion":[{"value":"2022-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}